Published in Oncology on January 01, 2003
Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol (2014) 1.21
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies. Ther Adv Med Oncol (2014) 1.13
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. Ann Oncol (2009) 1.02
The role of chemotherapy in the treatment of patients with brain metastases from solid tumors. Int J Clin Oncol (2009) 0.93
Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients. Onco Targets Ther (2013) 0.87
Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases. Oncotarget (2015) 0.85
Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors. Radiat Oncol (2006) 0.82
Advantages of a unique DNA-based vaccine in comparison to paclitaxel in treatment of an established intracerebral breast cancer in mice. Cancer Ther (2006) 0.77
Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis. Biomed Res Int (2016) 0.76
Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis. Cancer Med (2016) 0.76
Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases. Thorac Cancer (2016) 0.75
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma. Onco Targets Ther (2016) 0.75
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future. Transl Lung Cancer Res (2016) 0.75
State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer. Transl Lung Cancer Res (2016) 0.75
Systemic treatment of non-small cell lung cancer brain metastases. Contemp Oncol (Pozn) (2016) 0.75
Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy. Transl Lung Cancer Res (2016) 0.75
Oligometastatic non-small-cell lung cancer: current treatment strategies. Lung Cancer (Auckl) (2016) 0.75
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors. J Clin Oncol (2008) 5.28
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res (2009) 2.80
Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer (2009) 2.62
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis (2009) 2.41
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. J Clin Oncol (2014) 2.17
Progress against solid tumors in danger: the metastatic breast cancer example. J Clin Oncol (2012) 2.05
Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev (2011) 1.98
A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology (2003) 1.90
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer. J Clin Oncol (2010) 1.83
Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res (2008) 1.72
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06). Lancet Oncol (2010) 1.67
Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma. Am J Respir Crit Care Med (2010) 1.66
Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.61
Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer (2008) 1.56
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial. Eur Urol (2012) 1.50
MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells (2011) 1.49
The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release. Proc Natl Acad Sci U S A (2002) 1.42
miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol Cancer Ther (2010) 1.42
A phase I pharmacokinetic and pharmacodynamic study of dalotuzumab (MK-0646), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in patients with advanced solid tumors. Clin Cancer Res (2011) 1.36
Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients. Breast Cancer Res Treat (2008) 1.25
Nonreferral of possible soft tissue sarcomas in adults: a dangerous omission in policy. Sarcoma (2009) 1.21
Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology (2013) 1.21
Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft. J Clin Oncol (2011) 1.21
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer. Sci Signal (2014) 1.20
Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer. J Clin Oncol (2010) 1.10
MicroRNAs as cancer players: potential clinical and biological effects. DNA Cell Biol (2007) 1.07
Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy. Clin Cancer Res (2014) 1.06
Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer. J Surg Oncol (2010) 1.05
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo. Mol Cancer (2010) 1.04
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer. Invest New Drugs (2014) 1.04
Cervical phrenic nerve block for intractable hiccups in cancer patients. J Natl Cancer Inst (2002) 0.98
Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am J Clin Oncol (2003) 0.97
Long-term results after resection for bone sarcoma pulmonary metastases. Eur J Cardiothorac Surg (2009) 0.95
Novel agents that target tublin and related elements. Semin Oncol (2006) 0.95
Intraoperative radiotherapy electron boost followed by moderate doses of external beam radiotherapy in resected soft-tissue sarcoma of the extremities. Radiother Oncol (2003) 0.94
Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancer. Cancer Res (2004) 0.92
Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array. World J Gastroenterol (2012) 0.91
Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients. J Immunol (2011) 0.89
Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer. Cancer Cytopathol (2014) 0.89
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study. Target Oncol (2014) 0.88
Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer. Eur J Nucl Med Mol Imaging (2014) 0.87
Alpha-fetoprotein positively regulates cytochrome c-mediated caspase activation and apoptosome complex formation. Eur J Biochem (2003) 0.87
Clinical development of combination strategies in immunotherapy: are we ready for more than one investigational product in an early clinical trial? Immunotherapy (2009) 0.87
Use of customized-mold brachytherapy in the management of malignancies arising in the maxillary antrum after maxillectomy: a dosimetric analysis. Brachytherapy (2010) 0.86
MicroRNA profile in very young women with breast cancer. BMC Cancer (2014) 0.85
Nitric oxide triggers mammary gland involution after weaning: remodelling is delayed but not impaired in mice lacking inducible nitric oxide synthase. Biochem J (2010) 0.85
Nitration of cathepsin D enhances its proteolytic activity during mammary gland remodelling after lactation. Biochem J (2009) 0.84
Moving forward in colorectal cancer research, what proteomics has to tell. World J Gastroenterol (2007) 0.84
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo. Int J Cancer (2010) 0.83
Gene Expression Profiling of Tumors From Heavily Pretreated Patients With Metastatic Cancer for the Selection of Therapy: A Pilot Study. Am J Clin Oncol (2017) 0.83
Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: a phase II study. Clin Colorectal Cancer (2002) 0.83
Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy. Oncologist (2007) 0.83
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors. Cancer Chemother Pharmacol (2008) 0.83
KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients. Oncol Lett (2013) 0.83
Clinical practice guidelines on antiemetics in oncology. Expert Rev Anticancer Ther (2005) 0.82
Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes? Breast (2011) 0.82
Determinants of patient satisfaction with care in a Spanish oncology day hospital and its relationship with quality of life. Psychooncology (2013) 0.82
New approach to cancer therapy based on a molecularly defined cancer classification. CA Cancer J Clin (2013) 0.82
Second-line chemotherapy with irinotecan and vinorelbine in stage IIIB and IV non-small-cell lung cancer: a phase II study. Am J Clin Oncol (2002) 0.82
Rapid genetic targeting of pial surface neural progenitors and immature neurons by neonatal electroporation. Neural Dev (2012) 0.82
Comparing the clinical and radiological outcomes of pedicular transvertebral screw fixation of the lumbosacral spine in spondylolisthesis versus unilateral transforaminal lumbar interbody fusion (TLIF) with posterior fixation using anterior cages. Spine (Phila Pa 1976) (2008) 0.82
Satraplatin, an oral platinum, administered on a five-day every-five-week schedule: a pharmacokinetic and food effect study. Clin Cancer Res (2009) 0.81
Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol (2005) 0.81
Extended transcaruncular approach using detachment and repositioning of the inferior oblique muscle for the traumatic repair of the medial orbital wall. Craniomaxillofac Trauma Reconstr (2009) 0.81
Efficacy of sequential treatment with sunitinib-everolimus in an orthotopic mouse model of renal cell carcinoma. Anticancer Res (2012) 0.81
Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: a phase II study. Breast Cancer Res Treat (2002) 0.80
Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2007) 0.80
The expression of heat shock protein HSP60A reveals a dynamic mitochondrial pattern in Drosophila melanogaster embryos. J Proteome Res (2008) 0.80
Computer simulations of catanionic surfactants adsorbed at air/water interfaces. II. Full coverage. J Chem Phys (2007) 0.80
Structure and dynamics of nonionic surfactants adsorbed at vacuum/ionic liquid interfaces. Langmuir (2013) 0.80
A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors. Am J Clin Oncol (2009) 0.79
An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer. Breast (2013) 0.79
Dysregulation of apoptosis is a major mechanism in the lymph node involvement in colorectal carcinoma. Oncol Rep (2004) 0.79
Improving Total-Cholesterol/HDL-Cholesterol Ratio Results in an Endothelial Dysfunction Recovery in Peripheral Artery Disease Patients. Cholesterol (2012) 0.78
Phase I-IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours. Eur J Cancer (2013) 0.78
Activity of gefitinib in central nervous system metastases in patients with non-small-cell lung cancer: two case reports and a review of the literature. Clin Lung Cancer (2005) 0.78
Structure and dynamics of liquid methanol confined within functionalized silica nanopores. J Chem Phys (2010) 0.78
Non-clear cell advanced kidney cancer: is there a gold standard? Anticancer Drugs (2011) 0.77
Treatment of malignancy by activation of the plasminogen system. Semin Thromb Hemost (2002) 0.77
NF-ĸB as node for signal amplification during weaning. Cell Physiol Biochem (2011) 0.77
The cancer outpatient satisfaction with care questionnaire for chemotherapy, OUT-PATSAT35 CT: a validation study for Spanish patients. Support Care Cancer (2012) 0.77
Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report. Br J Clin Pharmacol (2011) 0.77
Impact of radiotherapy on the quality of life of elderly patients with localized breast cancer. A prospective study. Clin Transl Oncol (2008) 0.77
Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer. a feasibility pilot study. Oncology (2002) 0.77
Acute severe hypothyroidism induced by sunitinib. Radiother Oncol (2008) 0.76
Irreversible thermochromic behavior in gold and silver nanorod/polymeric ionic liquid nanocomposite films. ACS Appl Mater Interfaces (2009) 0.76
Radiation therapy after high-dose chemotherapy with peripheral blood stem cell support for high-risk breast cancer. Am J Clin Oncol (2002) 0.76